Opinion
 
  Entresto, inpatient therapy, and surrogate markers
- Author:
- Sidney Goldstein, MD
One overriding factor behind the slow uptake of Entresto for heart failure may be the cost of the drug compared to enalapril.
Opinion
 
  Are guidelines relevant?
- Author:
- Sidney Goldstein, MD
RCTs represent a very special subset of any disease process but they are the best we can do.
Opinion
 
  Who’s increasing health care costs? Not us!
- Author:
- Sidney Goldstein, MD
Community leadership has been minimized, and where it exists, it is under constant pressure to make a profit.
Opinion
 
  Medical ethics and economics
- Author:
- Sidney Goldstein, MD
It’s up to physicians to build an ethical wall between interests in clinical research.
News
The end of aspirin for primary prevention
- Author:
- Sidney Goldstein, MD
Aspirin for the primary prevention of cardiovascular events is dead, so why does the CDC keep pushing it?...
News
 
  Heart cell transplant rejections
- Author:
- Sidney Goldstein, MD
Piero Anversa’s fraudulent research led to an NIH study in humans that is still ongoing.
Opinion
 
  I’M NOT A PROVIDER
- Author:
- Sidney Goldstein, MD
Health care isn’t a commodity, and patients aren’t customers. We’re not talking about shoes.
News
 
  On cardiology training
- Author:
- Sidney Goldstein, MD
I recently received a letter from a former fellow who completed his training almost 25 years ago, thanking me for guiding him through his...
News
 
  ‘If this is an emergency, call 911’
- Author:
- Sidney Goldstein, MD
Or, don’t even try speaking directly your doctor.
Opinion
 
  Beta-blocker therapy post AMI
- Author:
- Sidney Goldstein, MD
Stick with beta-blocker therapy until evidence shows why not to use it.
Opinion
 
  CMS clinical trials raise cardiac mortality
- Author:
- Sidney Goldstein, MD
Health agencies should take their cues from randomized clinical trial designs to avoid unintended consequences.
Article
 
  PCI or CABG in the high-risk patient
- Author:
- Sidney Goldstein, MD
The recent report from the SYNTAX trials should give pause to our interventionalist colleagues embarking on multiple angioplasty and stenting...
Article
 
  TOPCAT, a third time around
- Author:
- Sidney Goldstein, MD
TOPCAT is back again, having randomized its first patient with heart failure with preserved ejection fraction (HFpEF) almost 10 years ago for its...
News
 
  Medical quality beats patient comfort
- Author:
- Sidney Goldstein, MD
News
The new heart failure: A call for new research initiatives
- Author:
- Sidney Goldstein, MD
Progress in treating ischemic heart disease has resulted in more patients with heart failure, and we must work to develop more effective heart...
 
                                                    